US 11,766,564 B2
Ocular stimulation method and system
Blair P. Mowery, College Grove, TN (US); Marshall T. Masko, Minnetonka, MN (US); John B. Jarding, Rapid City, SD (US); and Gary A. Tapp, Plymouth, MN (US)
Assigned to i-Lumen Scientific, Inc., Bloomington, MN (US)
Filed by i-Lumen Scientific, Inc., Bloomington, MN (US)
Filed on Sep. 30, 2022, as Appl. No. 17/957,842.
Application 17/957,842 is a continuation of application No. 17/831,374, filed on Jun. 2, 2022, granted, now 11,458,316.
Application 17/831,374 is a continuation of application No. 17/460,047, filed on Aug. 27, 2021, granted, now 11,351,374, issued on Jun. 7, 2022.
Application 17/460,047 is a continuation of application No. 17/079,287, filed on Oct. 23, 2020, granted, now 11,103,705, issued on Aug. 31, 2021.
Application 17/079,287 is a continuation of application No. 16/943,814, filed on Jul. 30, 2020, granted, now 11,065,447, issued on Jul. 20, 2021.
Application 16/943,814 is a continuation of application No. 16/851,853, filed on Apr. 17, 2020, granted, now 10,874,858, issued on Dec. 29, 2020.
Application 16/851,853 is a continuation of application No. 16/551,672, filed on Aug. 26, 2019, granted, now 10,682,514, issued on Jun. 16, 2020.
Application 16/551,672 is a continuation of application No. 15/759,515, granted, now 10,391,312, issued on Aug. 27, 2019, previously published as PCT/US2016/051550, filed on Sep. 13, 2016.
Claims priority of provisional application 62/365,838, filed on Jul. 22, 2016.
Claims priority of provisional application 62/283,871, filed on Sep. 15, 2015.
Claims priority of provisional application 62/283,870, filed on Sep. 15, 2015.
Prior Publication US 2023/0028327 A1, Jan. 26, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61N 1/04 (2006.01)
CPC A61N 1/36046 (2013.01) [A61N 1/0456 (2013.01); A61N 1/0476 (2013.01); A61N 1/0496 (2013.01); A61N 1/36014 (2013.01); A61N 1/36031 (2017.08); A61N 1/36034 (2017.08)] 21 Claims
OG exemplary drawing
 
1. A method comprising:
providing a first electrode substrate, wherein the first electrode substrate includes:
a first plurality of electrodes on the first electrode substrate that are configured to apply tissue-stimulation electrical-current therapy to a first eye of a patient in a room, the first eye having an upper eyelid and a lower eyelid, wherein the first electrode substrate is configured to locate the first plurality of electrodes on an outer surface of at least one of the upper eyelid and the lower eyelid of the patient's first eye, and wherein each one of the first plurality of electrodes is configured to be individually activated;
placing the first electrode substrate on the patient's skin such that the first plurality of electrodes is on the outer surface of at least one of the upper eyelid and the lower eyelid of the patient's first eye;
applying the tissue-stimulation electrical-current therapy applied to the first eye;
providing sensors;
sensing, using the sensors, ambient-light characteristics of the room during the applying of the tissue-stimulation electrical-current therapy; and
determining whether the ambient-light characteristics of the room affect an efficacy of the tissue-stimulation electrical-current therapy.